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Abstract:
Introduction and background: Development of new vesicular forms of drug
delivery systems; like proniosomes, niosomes and liposomes have brought larg head
wey in the novel drug carrier systems. Introducing of this novel drug delivery systems
cause to increase the local penetration, absorbtion of drug and also decrease in side
effect" Dithranol belongs to the keratolytic category, which is widely used drug in thy
treatment of psoriasis" This drug is practically in soluble in water.
Many conventional dosages, forms for psoriasis treatment have been formulated earlier,
but they did not show good results. Therefor the purpose of this study, it was attempted
to formulate Dithranol in the form of niosomes and evaluate the physico chemical
properties, till in the latter steps more evaluate in the clinical treatment.
Methods: In this study niosomes of Dithranol were obtained by film hydration
method" Different kinds of sorbitanesters (Span 20,40, 60 and 80), polysorbates
(Tween20,40, 60 and 80) in the presence of cholesterol were used in vesicular
formulations. [n vitro characterization of niosomes including microscopic observation,
release of Dithranol of niosomes, size analysis, physical stability during 6 monthes
period, the presence of cristal or surfactant drop and encapsulation efficiency
calculation were studied. Dithranol concentration was measured by second derivative
UV spectroscopy at 360 nm.
Results: Among the all niosomes formulation of Dithranol only span/tween 40 (50:50)
0.25% selected as preferable niosomal formulation because no oxidation and
sedimentation were detected. Vesicles were spherical multi 
- 
lamellar. The obtained
Average particle size was 6.183 pm. Vesicles were stable with minimum size change
during 6 monthes storage at refrigerator temperature. The maximum encapsulation
efficiency percent of Dithranol was 94.66%. 19.82% of dithranol was released from
niosomes over a period of 300 minutes.
Discussion and conclusion: High confined percent of the composition, relatively
good stability of noisome during storage at refrigerator temperature, the appropriate
particle size distribution and extended release of the confined Dithranol and using the
prepared noisome propose the likelihood of drug topical application improvement
success.
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